{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:12:35Z","timestamp":1786990355751,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"vor","delay-in-days":349,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ihj.2015.03.016","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T20:02:30Z","timestamp":1430164950000},"page":"227-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-9347","authenticated-orcid":false,"given":"Sabitha","family":"Palazhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodaran M.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2015.03.016_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0735-1097(02)02030-2","article-title":"ACC\/AHA\/NHLBI advisory on the use and safety of statins","volume":"40","author":"Pasternak","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.03.016_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/clp.10.47","article-title":"Targeting apo B as a therapeutic approach for the treatment of dyslipidemia: the potential role of mipomersen","volume":"5","author":"Thomas","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.ihj.2015.03.016_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2710.2011.01244.x","article-title":"Optimal therapy for reduction of lipoprotein (a)","volume":"37","author":"Lippi","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ihj.2015.03.016_bib4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","article-title":"Lowering blood homocysteine with folic acid based supplements: meta analysis of randomized trials","volume":"316","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ihj.2015.03.016_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty person\/ten-country panel","volume":"259","author":"Barter","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.ihj.2015.03.016_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.03.016_bib7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2015.03.016_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/HJR.0b013e3280111e41","article-title":"Oxidative stress, and iron and antioxidant status in elderly men: differences between the Mediterranean south (Crete) and northern Europe (Zutphen)","volume":"14","author":"Buijsse","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.ihj.2015.03.016_bib9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1194\/jlr.M500335-JLR200","article-title":"Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia","volume":"46","author":"Myerson","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ihj.2015.03.016_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/BTER:98:2:119","article-title":"Effects of statins on oxidative stress","volume":"98","author":"Yilmaz","year":"2004","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.ihj.2015.03.016_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk. An analysis from the JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.03.016_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2362.2007.01911.x","article-title":"Direct effect of statins on homocysteine-induced endothelial adhesiveness: potential impact to human atherosclerosis","volume":"38","author":"Lin","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ihj.2015.03.016_bib13","first-page":"56","article-title":"Risk factor profile for chronic non-communicable diseases: results of a community based study in Kerala, India","volume":"131","author":"Thankappan","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ihj.2015.03.016_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12038-013-9313-z","article-title":"Altered DNA repair, oxidative stress and antioxidant status in coronary artery disease","volume":"38","author":"Simon","year":"2013","journal-title":"J Biosci"},{"key":"10.1016\/j.ihj.2015.03.016_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.ihj.2015.03.016_bib16","first-page":"882","article-title":"Improved methods for the determination of glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ihj.2015.03.016_bib17","first-page":"158","article-title":"Studies on the qualitative and quantitative characterization of glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ihj.2015.03.016_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0006-291X(76)90747-6","article-title":"Glutathione peroxidase activity in selenium deficient rat liver","volume":"71","author":"Lawrence","year":"1976","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ihj.2015.03.016_bib19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diab.38.12.1539","article-title":"Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes","volume":"38","author":"Jain","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.ihj.2015.03.016_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ihj.2015.03.016_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02712155","article-title":"Assay of superoxide dismutase activity in animal tissues","volume":"13","author":"Nandi","year":"1988","journal-title":"J Biosci"},{"key":"10.1016\/j.ihj.2015.03.016_bib22","series-title":"Tietz Textbook of Clinical Chemistry","first-page":"999","article-title":"Vitamins","author":"McCormick","year":"1999"},{"key":"10.1016\/j.ihj.2015.03.016_bib23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ihj.2015.03.016_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2008.04.003","article-title":"Gene-environment interaction and oxidative stress in cardiovascular disease","volume":"200","author":"Stephens","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2015.03.016_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/eurheartj\/ehm565","article-title":"Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E","volume":"29","author":"Cangemi","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2015.03.016_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/clc.20724","article-title":"Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease","volume":"33","author":"Li","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2015.03.016_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9150(03)00053-4","article-title":"High oxidative stress among patients with coronary heart disease","volume":"168","author":"Weinbrenner","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ihj.2015.03.016_bib28","first-page":"503","article-title":"Study of oxidative stress in type 2 diabetic patients and its relationship with glycated haemoglobin","volume":"29","author":"Goodarzi","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ihj.2015.03.016_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbt.10058","article-title":"Diabetes, oxidative stress and antioxidants: a review","volume":"17","author":"Maritim","year":"2003","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.ihj.2015.03.016_bib30","doi-asserted-by":"crossref","first-page":"I7","DOI":"10.1002\/clc.4960261304","article-title":"New dimension of statin action on apo B atherogenecity","volume":"26","author":"Chapman","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ihj.2015.03.016_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2008.04.052","article-title":"Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol among high risk patients","volume":"52","author":"Ballantyne","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.03.016_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.CIR.80.5.1313","article-title":"HMG-CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels","volume":"80","author":"Kostner","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2015.03.016_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/heart.89.8.893","article-title":"Long term statin treatment significantly reduces lipoprotein (a) concentrations in heterozygous familial hypercholesterolemia","volume":"89","author":"vanWissen","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ihj.2015.03.016_bib34","first-page":"23","article-title":"Lipoprotein (a) and cholesterol in low and high density lipoproteins in patients with coronary artery disease","volume":"19","author":"Narayani","year":"1999","journal-title":"Biomedicine"},{"key":"10.1016\/j.ihj.2015.03.016_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(05)77220-2","article-title":"Lipid lowering drugs and homoysteine","volume":"353","author":"Lorgeril","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2015.03.016_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00382-0","article-title":"Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidemia (fenofibrate versus atorvastatin trial \u2013 FAT)","volume":"52","author":"Malik","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ihj.2015.03.016_bib37","first-page":"44","article-title":"Absence of association between serum homocysteine levels and coronary artery disease in South Indian males","volume":"53","author":"Deepa","year":"2001","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2015.03.016_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0972-2327.93270","article-title":"Low cholesterol as a risk factor for primary intracerebral haemorrhage: a case-control study","volume":"15","author":"Valappil","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.ihj.2015.03.016_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0735-1097(01)01415-2","article-title":"Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5)","volume":"38","author":"Mohan","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2015.03.016_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02913092","article-title":"Oxidized LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease","volume":"21","author":"Ghosh","year":"2006","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ihj.2015.03.016_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"18","author":"Jellinger","year":"2010","journal-title":"Endocr Pract"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T22:53:45Z","timestamp":1537656825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483215000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0019483215000838"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2015.03.016","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2015.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Cardiological Society of India. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}